Research & Development (R&D)

Eisai’s Supplementary New Drug Application Submitted In Japan for Fycompa

As Monotherapy for Partial-Onset Seizures, Pediatric Indication for Partial-Onset Seizures, as Well as New Formulation Tokyo, February 03, 2019: Eisai Co., Ltd.…

6 years ago

Wockhardt Receives US FDA Approval for Leukemia drug

 Mumbai, January 27, 2019: Pharmaceutical and biotechnology major Wockhardt has received approval from the United States Food & Drug Administration (US…

6 years ago

MTaI Seeks Streamlining of Taxes & Duties to Make Medical Devices Affordable

Sends 8-point agenda to Finance Ministry for inclusion in Budget FY’20 Mumbai, 21 January 2019: Medical Technology Association of India (MTaI),…

6 years ago

US FDA accepts regulatory submissions for review of tafamidis to treat transthyretin amyloid cardiomyopathy

New Delhi, January 16, 2019: Pfizer Inc. announced today that the US Food and Drug Administration (FDA) accepted for filing…

6 years ago

ICRA assigns stable outlook for Indian Pharma companies

New Delhi, January 04, 2018: ICRA has given a stable outlook on the Indian pharmaceutical industry. The headwinds from pricing pressure in…

6 years ago

Panav Bio-Tech Introduces Classical Swine Fever – Himmvac Hog Cholera (T/C) Vaccine in India

New Delhi, December 06, 2018: Panav Bio-Tech, a leading company in the animal healthcare, is now offering a vaccine for classical…

6 years ago

Cliantha Research holds Respiratory Symposium

New Delhi, November 25, 2018: As we know the Respiratory Clinical Development is becoming more and more challenging due to…

6 years ago

Out of the fog: honeycomb films

Research into porous films made via the condensation of humid air could lead to materials with applications ranging from medicine…

6 years ago

National Insulin Summit draws over 300 leading Indian doctors to discuss innovations in insulin therapy

Hyderabad, November 20, 2018: The National Insulin Summit, one of India’s most prestigious medical symposiums, conducted by Diabetes Research Society (DIABAID) and…

6 years ago

BIOCAD and SPHagree to build a drug substance manufacturing facility in China

New Delhi, November 20, 2018: This yearat theEastern Economic Forum in Vladivostok, BIOCAD andShanghai Pharmaceuticals Holdingentered into a Memorandum of…

6 years ago